IS-002 Phase 2 Prostate Cancer Study

Summary

Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da Vinci® X/Xi Surgical System with Firefly® Fluorescence Imaging.

Timeline

Start

2023-06-16

Primary completion

2024-05-21

Completion

2025-05-23

Drugs

Indications